2008
DOI: 10.1016/j.fertnstert.2007.05.053
|View full text |Cite
|
Sign up to set email alerts
|

Mifepristone attenuates human chorionic gonadotropin–induced extracellular signal–regulated kinase 1/2 phosphorylation, cyclooxygenase-2, and prostaglandin E2 production in human granulosa luteal cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 48 publications
1
3
0
Order By: Relevance
“…Using the ERK1/2 phosphorylation blocker PD98059, we discovered that MMP-2 upregulation resulted from ERK1/2 phosphorylation. ERK1/2 have been proved to contribute to tumor proliferation, migration and metastasis, and several studies reported that hCG promoted the ERK1/2 activation in some cell types [30], [31]. Obviously, these results are consistent with our results that hCG induced ERK1/2 phosphorylation in a dose- and time-dependent manners in DU145 cells.…”
Section: Discussionsupporting
confidence: 93%
“…Using the ERK1/2 phosphorylation blocker PD98059, we discovered that MMP-2 upregulation resulted from ERK1/2 phosphorylation. ERK1/2 have been proved to contribute to tumor proliferation, migration and metastasis, and several studies reported that hCG promoted the ERK1/2 activation in some cell types [30], [31]. Obviously, these results are consistent with our results that hCG induced ERK1/2 phosphorylation in a dose- and time-dependent manners in DU145 cells.…”
Section: Discussionsupporting
confidence: 93%
“…The dosage of inhibitors was chosen based on previously published studies (19, 24, 25), and our pilot study showing a dose-dependent response (data not shown). RU486 had no effect on P4 levels both in control and hCG-stimulated cells [Fig.…”
Section: Resultsmentioning
confidence: 99%
“…BDMC significantly inhibited ERK1/2 but increased p-ERK1/2 in Hela cells ( Figure 5A). ERK1/2 have been shown to contribute to cancer cell proliferation, migration and metastasis in some cell lines (45,46) and increased p-ERK1/2 activity promotes cancer cell proliferation and metastasis in various cancer cell lines (47)(48)(49). Our findings indicate that BDMC reduced MMP-2 and -9 activities and protein expression, which may be via ERK1/2 phosphorylation, and it also inhibited the vimentin pathway in HeLa cells.…”
Section: Discussionmentioning
confidence: 51%